Crupi, Rosalia
Impellizzeri, Daniela
Cordaro, Marika
Siracusa, Rosalba
Casili, Giovanna
Evangelista, Maurizio
Cuzzocrea, Salvatore http://orcid.org/0000-0001-6131-3690
Article History
Received: 15 September 2017
Accepted: 12 February 2018
First Online: 19 March 2018
Compliance with Ethical Standards
:
: Salvatore Cuzzocrea is co-inventor on patent WO2013121449 A8 (Epitech Group Srl) which deals with methods and compositions for the modulation of amidases capable of hydrolysingN-acylethanolamines employable in the treatment of inflammatory diseases. This invention is wholly unrelated to the present study. Moreover, Prof. Cuzzocrea is also, with Epitech Group, a co-inventor on the following patent: EP 2821083; MI2014 A001495; 102015000067344 that are however unrelated to the study.
: The authors declare that they have no conflict of interest.